Delivery Order SPE2DB22D3010-SPE2DB24FP2BH
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,343.59 Firm Fixed Price delivery order contract is for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through March 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,343.59 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a period of performance ending on July 10, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $4,530.60 firm fixed-price delivery order is for the pharmaceutical product TEZSPIRE 210 mg/1.91 ml pen. The contract has a completion date of May 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 firm-fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order worth $4,530.60 for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of July 31, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,530.60 Firm Fixed Price delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a performance period ending on July 23, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to...
- This federal contract award, valued at $4,530.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through July 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,061.20 Firm Fixed Price delivery order covers the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product, with a period of performance through December 2, 2024. This award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP2BHDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,265.29 firm fixed price delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a performance period running through April 24, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA that serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. This specific delivery order was issued under that IDC, which does not have any set-aside designation. Amerisourcebergen Drug Corp has extensive experience as a prime contractor delivering a wide range of medications and critical care supplies to the U.S. government, particularly the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/3/24 |